MedTrace Logo

The EFFORT Trial and EFFORT Outcomes Sub-study (EFFORT-Outcomes)

NCT04931940 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 142

Last updated 2021-09-01

No results posted yet for this study

Summary

The investigators will evaluate the effects of higher protein/amino acid dosing (≥2.2 g/kg/d) vs usual care of protein/amino acid dosing (≤1.2 g/kg/d) over muscle mass in nutritionally high risk ill patients

Conditions

  • Critical Illness
  • Malnutrition

Interventions

DIETARY_SUPPLEMENT

Usual Care

Patients will receive the usual protein dosage at ≤1.2 g/kg/day for up to 28 days in the ICU

DIETARY_SUPPLEMENT

Higher Protein/Amino Acid Group

Patients will receive high protein dosage at ≥2.2 g/kg/day for up to 28 days in the ICU

Sponsors & Collaborators

  • Clinical Evaluation Research Unit at Kingston General Hospital

    lead OTHER

Principal Investigators

  • Daren K Heyland, DM · Clinical Evaluation Research Unit

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-01
Primary Completion
2022-12-01
Completion
2022-12-01

Countries

  • Australia
  • Malaysia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04931940 on ClinicalTrials.gov